ScholarLens Back to search
2007•International Journal of Antimicrobial AgentsRequires access

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

Karin Seifert, F. Javier Pérez‐Victoria, Marianne Stettler, María P. Sánchez‐Cañete, Santiago Castanys, Francisco Gamarro, Simon L. Croft

Open publisher page 135 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 135 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Miltefosine, Amastigote, Leishmania donovani, In vivo, Leishmania, Biology, Visceral leishmaniasis, Leishmaniasis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo — Research Paper | ScholarLens